Actively Recruiting
Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection
Led by Consorci Sanitari de Terrassa · Updated on 2026-03-25
3000
Participants Needed
1
Research Sites
416 weeks
Total Duration
On this page
Sponsors
C
Consorci Sanitari de Terrassa
Lead Sponsor
F
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Collaborating Sponsor
AI-Summary
What this Trial Is About
Some authors have proposed the use of the flu vaccine to reduce the severity of COVID-19 cases, while some have proposed the use of ACE Inhibitors (ACEI) or Angiotensin Receptor blockers (ARB), since this virus shares hemagglutinin as a transmission mechanism and acts on the ACE2 enzyme during infection. Other authors described how none of the elderly patients receiving antihistamines and azythromycin in two nursing homes in Toledo -Spain- during the first wave died or needed hospital admission, even considering that 100% of residents had a positive serological test after that wave. Other authors have described a positive evolution in patients receiving amantadine for their Parkinson's disease. The aim is to evaluate whether the admitted patients who are previously vaccinated or those who were already receiving these treatments showed a better evolution.
CONDITIONS
Official Title
Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hospital admissions at the Hospital of Terrassa from March 1, 2020 for any cause.
You will not qualify if you...
- Patients from outside the reference area of the Terrassa Health Consortium would be excluded for comparison of percentage of Influenza vaccination, ACEI and ARB vs general population.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital de Terrassa
Terrassa, Barcelona, Spain, 08227
Actively Recruiting
Research Team
A
Anna Puigdellívol-Sánchez, Ph.D.
CONTACT
M
Mar Muñoz
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here